Home
Octave Bioscience

Octave Bioscience Market Share Analysis for July 2026

Contact Octave Bioscience for clinical, patient, ordering, or partnership inquiries related to the Octave MSDA Test and precision neurology in MS.

Industry: N/A

Domainoctavebio.com

Year Founded2014

Employees51 - 200

Annual Revenue$25M - $50M

Octave Bioscience

Octave Bioscience (including company regionals)

octavebio.com

See more website traffic and engagement information

Octave Bioscience Revenue up to July 2026 is 25M - 50M

revenue generated by Octave Bioscience top domains

Octave Bioscience top domains revenue over 3 years

Revenue for Octave Bioscience top domains

octavebio.com25M - 50M

See more with Sales Intelligence

Total visits to Octave Bioscience's top domains

Understand Octave Bioscience market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

octavebio.com3.9K

See more with Sales Intelligence

Avg. visit duration in Octave Bioscience's top domains

Analyze Octave Bioscience engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

octavebio.com00:00:47

See more with Sales Intelligence

Avg. pageviews on Octave Bioscience's top domains

See how Octave Bioscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

octavebio.com2.07

See more with Sales Intelligence

Octave Bioscience top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Octave Bioscience

These are the website technologies, by industry, used by Octave Bioscience top domains

Advertising (29)

DoubleClick

Widget (7)

Twemoji

Content Management System (5)

WordPress

Conversion & Analytics (5)

Google Analytics

More Technologies

11

See all

News & Signals from Octave Bioscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOctavebio hired Kirk Stockwood as Senior Vice President, Commercial on Jan 8th '26.Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases today announced the appointment of Kirk Stockwood as Senior Vice President, Commercial.

NewsSilicon Valley Bank invests into Octavebio $15.5M in loan.Octave also secured a $15.5 million loan from Silicon Valley Bank, a division of First Citizens Bank.

NewsOctavebio received financing of $35.6M in Series C on Sep 4th '25.NEW YORK - Octave Bioscience said Thursday that it has closed a $35.6 million Series C funding round and entered into a $15.5 million non-dilutive term loan agreement with Silicon Valley Bank.